Sociedad Qu mica y Minera de Chile S.A. and GE Healthcare's Pharmaceutical Diagnostics business have announced a long-term agreement, to secure its supply of iodine, a key ingredient for contrast media products used in X-Ray and Computed Tomography (CT) procedures globally. The agreement will see SQM increase supply of iodine raw material year-on-year and is part of GE Healthcare's broader commitment and investment plan to enable the production of 30 million more patient doses of iodinated contrast media annually by 2025.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
47.77 USD | -0.40% | +1.59% | -20.36% |
04-24 | Tianqi Lithium Forecasts Loss in Q1 | MT |
04-24 | Tianqi Lithium Shares Dive After Warning of Wider Losses | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.36% | 13.7B | |
+15.43% | 65.38B | |
+0.15% | 47.8B | |
+15.79% | 40.65B | |
+23.50% | 26.69B | |
+11.53% | 19.24B | |
+2.39% | 17.75B | |
-21.87% | 16B | |
-9.48% | 15.37B | |
+3.42% | 15.23B |
- Stock Market
- Equities
- SQM Stock
- News Sociedad Química y Minera de Chile S.A.
- Sociedad Química Y Minera De Chile S.A. Announces Long-Term Agreement